急性脳血管閉塞症例に対する血管内治療─血栓回収療法導入前後での比較
「はじめに」脳梗塞急性期の治療は, 脳卒中ガイドラインの作成, 薬剤や治療機器の開発により, めざましく進歩している. 日本では2005年10月からrecombinant tissue-plasminogen activator(rt-PA:アルテプラーゼ)静注療法が認可され, 禁忌項目を有さない発症4.5時間以内の脳梗塞患者に対する標準的治療となっている. 一方で, 血管内治療は発症6時間以内の中大脳動脈閉塞症例に対する局所線溶療法の有効性が報告され, 脳血管拡張用バルーンを用いた血管形成, 血栓破砕を組み合わせて行うようになった. 経皮的経管的脳血栓回収療法はMerci Retrieval...
Saved in:
Published in | 脳卒中の外科 Vol. 44; no. 1; pp. 43 - 48 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
一般社団法人 日本脳卒中の外科学会
2016
日本脳卒中の外科学会 |
Subjects | |
Online Access | Get full text |
ISSN | 0914-5508 1880-4683 |
DOI | 10.2335/scs.44.43 |
Cover
Abstract | 「はじめに」脳梗塞急性期の治療は, 脳卒中ガイドラインの作成, 薬剤や治療機器の開発により, めざましく進歩している. 日本では2005年10月からrecombinant tissue-plasminogen activator(rt-PA:アルテプラーゼ)静注療法が認可され, 禁忌項目を有さない発症4.5時間以内の脳梗塞患者に対する標準的治療となっている. 一方で, 血管内治療は発症6時間以内の中大脳動脈閉塞症例に対する局所線溶療法の有効性が報告され, 脳血管拡張用バルーンを用いた血管形成, 血栓破砕を組み合わせて行うようになった. 経皮的経管的脳血栓回収療法はMerci Retrieval System(Concentric Medical社)およびPenumbra System(Penumbra社)が開発され, 発症8時間以内の内頚動脈, 中大脳動脈, 椎骨動脈, 脳底動脈の閉塞症例のうち, rt-PA静注療法の適応外またはrt-PA静注療法で血流再開が得られなかった症例を対象に, 日本では2010年10月に保険収載され現在広く行われている. |
---|---|
AbstractList | 「はじめに」脳梗塞急性期の治療は, 脳卒中ガイドラインの作成, 薬剤や治療機器の開発により, めざましく進歩している. 日本では2005年10月からrecombinant tissue-plasminogen activator(rt-PA:アルテプラーゼ)静注療法が認可され, 禁忌項目を有さない発症4.5時間以内の脳梗塞患者に対する標準的治療となっている. 一方で, 血管内治療は発症6時間以内の中大脳動脈閉塞症例に対する局所線溶療法の有効性が報告され, 脳血管拡張用バルーンを用いた血管形成, 血栓破砕を組み合わせて行うようになった. 経皮的経管的脳血栓回収療法はMerci Retrieval System(Concentric Medical社)およびPenumbra System(Penumbra社)が開発され, 発症8時間以内の内頚動脈, 中大脳動脈, 椎骨動脈, 脳底動脈の閉塞症例のうち, rt-PA静注療法の適応外またはrt-PA静注療法で血流再開が得られなかった症例を対象に, 日本では2010年10月に保険収載され現在広く行われている. |
Author | 関, 行雄 小島, 隆生 辻河, 高陽 遠藤, 邦幸 両角, 佐織 安井, 敬三 長谷川, 康博 |
Author_xml | – sequence: 1 fullname: 関, 行雄 organization: 名古屋第二赤十字病院 脳神経外科 – sequence: 1 fullname: 両角, 佐織 organization: 名古屋第二赤十字病院 神経内科 – sequence: 1 fullname: 辻河, 高陽 organization: 名古屋第二赤十字病院 神経内科 – sequence: 1 fullname: 安井, 敬三 organization: 名古屋第二赤十字病院 神経内科 – sequence: 1 fullname: 長谷川, 康博 organization: 名古屋第二赤十字病院 神経内科 – sequence: 1 fullname: 小島, 隆生 organization: 名古屋第二赤十字病院 脳神経外科 – sequence: 1 fullname: 遠藤, 邦幸 organization: 名古屋第二赤十字病院 神経内科 |
BookMark | eNo1UE1LAlEUfURBVi76Idr7mvENtIkoC4Q27h_P8U2N6SgztminlYXYxyIrJJBcRItAI5eFP6bpjfYvemLdxTmXc7jnXu4SmPfKngRgFcEkJsRYC-wgSWmSkjkQQ4zBBDUZmQcxaCGaMAzIFkE8CNwcxASZWrRiwI5qz1HtZXI2nPRq437v576pet3xw8X3qBXWX9VgFNY74Ulr5qrzRvT-Me6cfLVrWomebtVjV91cayUa3qm3a9V4Vs0rNboM6y9hvR8N2pPP0xWw4IhiION_vAyy21vZzZ1EZi-9u7mRSRQI1MdaWDgQ5QyWzzsOQQhToStnM4QxJjnHcYQ0JUEMmoIYEjsyb6QwpSkmLMsyyDJIz2JLMu_aolj2iq4neaF85Ht6LbcrNKj65UOOITI5hJRCpIlNWzIFhk3twJROWp8lFYKq2Je84rsl4R9z4Vdduyi5_jOnlKMp6NF_2T4QPi8I8gvJGJpS |
ContentType | Journal Article |
Copyright | 2016 一般社団法人 日本脳卒中の外科学会 |
Copyright_xml | – notice: 2016 一般社団法人 日本脳卒中の外科学会 |
CorporateAuthor | 名古屋第二赤十字病院 神経内科 名古屋第二赤十字病院 脳神経外科 |
CorporateAuthor_xml | – name: 名古屋第二赤十字病院 神経内科 – name: 名古屋第二赤十字病院 脳神経外科 |
DOI | 10.2335/scs.44.43 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1880-4683 |
EndPage | 48 |
ExternalDocumentID | cp4strok_2016_004401_008_0043_00482601607 article_scs_44_1_44_43_article_char_ja |
GroupedDBID | 123 2WC ABJNI ALMA_UNASSIGNED_HOLDINGS CS3 JSF KQ8 MOJWN OK1 RJT |
ID | FETCH-LOGICAL-j3080-92af01b58ddff31124aaaabc812223bfffae6e31806a35e2fed5724478a99953 |
ISSN | 0914-5508 |
IngestDate | Thu Jul 10 16:10:58 EDT 2025 Wed Sep 03 06:10:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 1 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j3080-92af01b58ddff31124aaaabc812223bfffae6e31806a35e2fed5724478a99953 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/scs/44/1/44_43/_article/-char/ja |
PageCount | 6 |
ParticipantIDs | medicalonline_journals_cp4strok_2016_004401_008_0043_00482601607 jstage_primary_article_scs_44_1_44_43_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 20160000 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – year: 2016 text: 20160000 |
PublicationDecade | 2010 |
PublicationTitle | 脳卒中の外科 |
PublicationTitleAlternate | Surg. Cereb. Stroke |
PublicationYear | 2016 |
Publisher | 一般社団法人 日本脳卒中の外科学会 日本脳卒中の外科学会 |
Publisher_xml | – name: 一般社団法人 日本脳卒中の外科学会 – name: 日本脳卒中の外科学会 |
References | 2) Ciccone A, Valvassori L, Nichelatti M, et al : Endovascular treatment for acute ischemic stroke. N Engl J Med 368: 904-913, 2013 14) 日本脳卒中学会脳卒中医療向上・社会保険委員会rt-PA(アルテプラーゼ)静注療法指針改訂部会:rt-PA(アルテプラーゼ)静注療法適正治療指針第二版.脳卒中 34: 441-480, 2012 18) Shi ZS, Liebeskind DS, Xiang B, et al : Predictors of functional dependence despite successful revascularization in largevessel occlusion strokes. Stroke 45: 1977-1984, 2014 20) Smith WS, Sung G, Starkman S, et al : Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36: 1432-1438, 2005 7) Hirano T, Sasaki M, Mori E, et al : Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II. Stroke 41: 2828-2833, 2010 3) De Silva DA, Brekenfeld C, Ebinger M, et al : The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 41: 295-299, 2010 8) Kim YS, Garami Z, Mikulik R, et al : Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke 36: 869-871, 2005 11) Marks MP, Olivot JM, Kemp S, et al : Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion-and diffusion-weighted imaging in the DEFUSE study. Radiology 249: 614-623, 2008 9) Lees KR, Bluhmki E, von Kummer R, et al : Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPI-THET trials. Lancet 375: 1695-1703, 2010 17) Saver JL, Jahan R, Levy EI, et al : Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380: 1241-1249, 2012 24) Yoshimura S, Sakai N, Okada Y, et al : Efficacy of endovascular treatment for acute cerebral large-vessel occlusion: analysis of nationwide prospective registry. J Stroke Cerebrovasc Dis 23: 1183-1190, 2014 6) Hayakawa M, Yamagami H, Sakai N, et al : Endovascular treatment of acute stroke with major vessel occlusion before approval of mechanical thrombectomy devices in Japan: Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET 2. Neurol Med Chir (Tokyo) 54: 23-31, 2014 21) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995 4) Furlan A, Higashida R, Wechsler L, et al : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003-2011, 1999 10) Linfante I, Llinas RH, Selim M, et al : Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33: 2066-2071, 2002 5) Hacke W, Kaste M, Bluhmki E, et al : Thrombolysis with alSurgery for Cerebral Stroke 44: 2016 47 teplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329, 2008 19) Smith WS, Sung G, Saver J, et al : Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39: 1205-1212, 2008 22) The Penumbra Pivotal Stroke Trial Investigators : The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40: 2761-2768, 2009 1) Broderick JP, Palesch YY, Demchuk AM, et al : Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368: 893-903, 2013 12) Mazighi M, Chaudhry SA, Ribo M, et al : Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation 127: 1980-1985, 2013 16) Ogawa A, Mori E, Minematsu K, et al : Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38: 2633-2639, 2007 23) Yamaguchi T, Mori E, Minematsu K, et al : Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37: 1810-1815, 2006 15) Nogueira RG, Lutsep HL, Gupta R, et al : Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380: 1231-1240, 2012 13) Nakashima T, Toyoda K, Koga M, et al : Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Int J Stroke 4: 425-431, 2009 |
References_xml | – reference: 18) Shi ZS, Liebeskind DS, Xiang B, et al : Predictors of functional dependence despite successful revascularization in largevessel occlusion strokes. Stroke 45: 1977-1984, 2014 – reference: 6) Hayakawa M, Yamagami H, Sakai N, et al : Endovascular treatment of acute stroke with major vessel occlusion before approval of mechanical thrombectomy devices in Japan: Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET 2. Neurol Med Chir (Tokyo) 54: 23-31, 2014 – reference: 10) Linfante I, Llinas RH, Selim M, et al : Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33: 2066-2071, 2002 – reference: 13) Nakashima T, Toyoda K, Koga M, et al : Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Int J Stroke 4: 425-431, 2009 – reference: 19) Smith WS, Sung G, Saver J, et al : Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39: 1205-1212, 2008 – reference: 17) Saver JL, Jahan R, Levy EI, et al : Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380: 1241-1249, 2012 – reference: 24) Yoshimura S, Sakai N, Okada Y, et al : Efficacy of endovascular treatment for acute cerebral large-vessel occlusion: analysis of nationwide prospective registry. J Stroke Cerebrovasc Dis 23: 1183-1190, 2014 – reference: 21) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995 – reference: 12) Mazighi M, Chaudhry SA, Ribo M, et al : Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation 127: 1980-1985, 2013 – reference: 14) 日本脳卒中学会脳卒中医療向上・社会保険委員会rt-PA(アルテプラーゼ)静注療法指針改訂部会:rt-PA(アルテプラーゼ)静注療法適正治療指針第二版.脳卒中 34: 441-480, 2012 – reference: 9) Lees KR, Bluhmki E, von Kummer R, et al : Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPI-THET trials. Lancet 375: 1695-1703, 2010 – reference: 2) Ciccone A, Valvassori L, Nichelatti M, et al : Endovascular treatment for acute ischemic stroke. N Engl J Med 368: 904-913, 2013 – reference: 4) Furlan A, Higashida R, Wechsler L, et al : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003-2011, 1999 – reference: 3) De Silva DA, Brekenfeld C, Ebinger M, et al : The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 41: 295-299, 2010 – reference: 5) Hacke W, Kaste M, Bluhmki E, et al : Thrombolysis with alSurgery for Cerebral Stroke 44: 2016 47 teplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329, 2008 – reference: 1) Broderick JP, Palesch YY, Demchuk AM, et al : Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368: 893-903, 2013 – reference: 11) Marks MP, Olivot JM, Kemp S, et al : Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion-and diffusion-weighted imaging in the DEFUSE study. Radiology 249: 614-623, 2008 – reference: 20) Smith WS, Sung G, Starkman S, et al : Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36: 1432-1438, 2005 – reference: 23) Yamaguchi T, Mori E, Minematsu K, et al : Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37: 1810-1815, 2006 – reference: 15) Nogueira RG, Lutsep HL, Gupta R, et al : Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380: 1231-1240, 2012 – reference: 22) The Penumbra Pivotal Stroke Trial Investigators : The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40: 2761-2768, 2009 – reference: 16) Ogawa A, Mori E, Minematsu K, et al : Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38: 2633-2639, 2007 – reference: 7) Hirano T, Sasaki M, Mori E, et al : Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II. Stroke 41: 2828-2833, 2010 – reference: 8) Kim YS, Garami Z, Mikulik R, et al : Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke 36: 869-871, 2005 |
SSID | ssib023160919 ssj0041830 ssib058493970 ssib005901896 ssib017628741 ssib000872179 ssib002484435 |
Score | 2.0473604 |
Snippet | 「はじめに」脳梗塞急性期の治療は, 脳卒中ガイドラインの作成, 薬剤や治療機器の開発により, めざましく進歩している. 日本では2005年10月からrecombinant... |
SourceID | medicalonline jstage |
SourceType | Publisher |
StartPage | 43 |
SubjectTerms | acute ischemic stroke endovascular treatment mechanical thrombectomy |
Title | 急性脳血管閉塞症例に対する血管内治療─血栓回収療法導入前後での比較 |
URI | https://www.jstage.jst.go.jp/article/scs/44/1/44_43/_article/-char/ja http://mol.medicalonline.jp/en/journal/download?GoodsID=cp4strok/2016/004401/008&name=0043-0048j |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 脳卒中の外科, 2016, Vol.44(1), pp.43-48 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1880-4683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0041830 issn: 0914-5508 databaseCode: KQ8 dateStart: 19870101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANNQKIoj4ifWLPTinkpqPSTJzM9lmKUIFoUJvIbubHFZsS7u9eOpWq5RqPfhFEYo9lB6EVuxR6Z9Zs61n_4Dvvdnspuqh1j0Ms2_evHnzXibz3mTmjabdghnAkmbMdZmaQuepCbl6DV-GienWbctz6Dqg8Xvu2AN-d9KZHDjxs7Brab5ZHak9_uu5kuNoFWCgVzwl-w-a7REFAORBv5CChiE9ko5Z6OJOBd_JMx4LBROcBTZmfBOBocf8EPOhZBLQJAsd_CtDLJIeE1ALqoRMBCy0wbRkfkA4FQQqiJSUsQjnT8oOE0CZ2AgsFgREWQL-sD5cwHeZbzBpI74MiAGoWGEi7OETBZtJB4sCg4ocpOwTBJgXo1QE3JZzbr08E1ITFSY5NhqUmbq9Jje-C8JxkI60qOPA3miBArTFUVDYO-Cq90jmHFUoY7PAJYn62HVkHypV-rgka9_KO18mSMAE76Oopk1C8XJmgCsSbADovEgOuTMQFzQGDIYkLd8lZiRQKi7fqHOlNNRQIliDdCPLzC8fTwoEGaUGOUpW-sVFXhh74IOK4nyn4m0eGtdq8lLxsrpmkIp_-vsEa9m2Q1eCzo1wPpJXOBSvvDbD55qz0w8j7G1EV5qbEd11anAbE0FR7DACxEnLA_MQd1LcL_oEnmUWPh3j4WjRjwlpwuwtvL4ND_6JC93s4YNBLcHGNnJzjMOcRQutuShUeDHsyO1eN8D8bIAzhlE2zjxSH0hVoJqCrTlxTjvbdRJLvhrx57WBRnxBOzXe3QZzUat1FjY7C1sHT3cPNhb2tzd-vFvONtb33z__vrfSbn3KdvbarbX24ooqzZ4tdb583V9bLOklgHQ-vs4-rGevVgHS2X2bfV7Nljaz5ZfZ3ot2a6vd2u7svDn49uSSNlEJJ8pjeve2FL1hg9unSytODbPqiHo9TW1wo3gMv2oNLHhwAappmsaJi188DDe2ncRKk7rjgXHviRicRMe-rA1OTU8lV7QSF9LyEhEblqxxWfeE5DKxzNQVMrW5Vx3SHCWtaEZFxIm6b8AIBBpxHpmYgLJzMB4gjRrxkHbnkHCj7qt0LjryM3P1_0lc004jilpGva4NNmfnkxvgWDSrN-lB_AWnlesJ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%80%A5%E6%80%A7%E8%84%B3%E8%A1%80%E7%AE%A1%E9%96%89%E5%A1%9E%E7%97%87%E4%BE%8B%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E8%A1%80%E7%AE%A1%E5%86%85%E6%B2%BB%E7%99%82+-+%E8%A1%80%E6%A0%93%E5%9B%9E%E5%8F%8E%E7%99%82%E6%B3%95%E5%B0%8E%E5%85%A5%E5%89%8D%E5%BE%8C%E3%81%A7%E3%81%AE%E6%AF%94%E8%BC%83&rft.jtitle=%E8%84%B3%E5%8D%92%E4%B8%AD%E3%81%AE%E5%A4%96%E7%A7%91&rft.au=%E5%B0%8F%E5%B3%B6%E9%9A%86%E7%94%9F&rft.au=%E9%96%A2%E8%A1%8C%E9%9B%84&rft.au=%E4%B8%A1%E8%A7%92%E4%BD%90%E7%B9%94&rft.au=%E9%81%A0%E8%97%A4%E9%82%A6%E5%B9%B8&rft.date=2016&rft.pub=%E6%97%A5%E6%9C%AC%E8%84%B3%E5%8D%92%E4%B8%AD%E3%81%AE%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0914-5508&rft.volume=44&rft.issue=1&rft.spage=43&rft.epage=48&rft_id=info:doi/10.2335%2Fscs.44.43&rft.externalDocID=cp4strok_2016_004401_008_0043_00482601607 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-5508&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-5508&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-5508&client=summon |